131 related articles for article (PubMed ID: 12187264)
21. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
[TBL] [Abstract][Full Text] [Related]
22. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
23. Construction of urothelium-specific recombinant adenovirus and its inhibition in bladder cancer cell.
He XD; Wang ZP; Wei HY; Zhou Q; Wang DG; Tian JQ; Fu SJ; Rodriguez R
Urol Int; 2009; 82(2):209-13. PubMed ID: 19322012
[TBL] [Abstract][Full Text] [Related]
24. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells.
Sakai N; Ohtsu M; Fujita H; Koike T; Kuzumaki N
Exp Cell Res; 1999 Aug; 251(1):224-33. PubMed ID: 10438588
[TBL] [Abstract][Full Text] [Related]
26. Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.
Wang L; Zhang Y; Zhao J; Xiao E; Lu J; Fu S; Wang Z
Tumour Biol; 2014 Nov; 35(11):10879-90. PubMed ID: 25085582
[TBL] [Abstract][Full Text] [Related]
27. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell lines.
Fukuhara H; Hayashi Y; Yamamoto N; Fukui T; Nishikawa M; Mitsudo K; Tohnai I; Ueda M; Mizuno M; Yoshida J
Oral Oncol; 2003 Sep; 39(6):601-9. PubMed ID: 12798404
[TBL] [Abstract][Full Text] [Related]
28. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis.
Crowley MR; Head KL; Kwiatkowski DJ; Asch HL; Asch BB
Dev Biol; 2000 Sep; 225(2):407-23. PubMed ID: 10985859
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Inoue K; Perrotte P; Wood CG; Slaton JW; Sweeney P; Dinney CP
Clin Cancer Res; 2000 Nov; 6(11):4422-31. PubMed ID: 11106263
[TBL] [Abstract][Full Text] [Related]
30. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
[TBL] [Abstract][Full Text] [Related]
31. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
[TBL] [Abstract][Full Text] [Related]
32. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis.
He D; Nan X; Chang KS; Wang Y; Chung LW
Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
35. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
[TBL] [Abstract][Full Text] [Related]
36. Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo.
Chen JP; Lin C; Xu CP; Zhang XY; Fu M; Deng YP; Wei Y; Wu M
J Gastroenterol Hepatol; 2001 Jan; 16(1):22-8. PubMed ID: 11206311
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model.
Cheon J; Moon DG; Cho HY; Park HS; Kim JJ; Gardner TA; Kao C
Int J Urol; 2002 May; 9(5):261-7. PubMed ID: 12060439
[TBL] [Abstract][Full Text] [Related]
38. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.
Kikuchi E; Menendez S; Ohori M; Cordon-Cardo C; Kasahara N; Bochner BH
Clin Cancer Res; 2004 Mar; 10(5):1835-42. PubMed ID: 15014038
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
O'Malley BW; Chen SH; Schwartz MR; Woo SL
Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]